GLD vs INBX
SPDR® Gold Shares (GLD) versus Inhibrx Biosciences, Inc. (INBX) — a side-by-side from cached financials, not a winner call.
SPDR® Gold Shares (GLD) common stock listed on NYSE ARCA.
Inhibrx Biosciences, Inc. (INBX) is a biotechnology company listed on US.
GLD does not have a complete income-statement cache yet.
Latest reported INBX revenue for 2025-12-31 was $1.3M. Net income was -$140.1M. Revenue was up 550.0% from 2024-12-31 to 2025-12-31. INBX currently screens at market cap $1.28B.
GLD currently screens at market cap $0. INBX currently screens at market cap $1.28B.
Not investment advice. Open the GLD and INBX stock pages for the full models.
Not investment advice.